Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RENOVITE BMP-2 (Renovos Biologics)
- Development stage
- Preclinical
- Lead developer
- Renovos Biologics
- Modality
- Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Recombinant Proteins and Enzymes
- Administration
- Injectable
01
Overview
RENOVITE BMP-2 is an injectable regenerative medicine product developed by Renovos Biologics. It consists of a proprietary synthetic nanoclay gel carrier (the RENOVITE platform) that binds and delivers Bone Morphogenetic Protein-2 (BMP-2). The nanoclay's high affinity for the growth factor prevents leaching into surrounding tissues, thereby reducing the risk of off-target bone formation and other safety concerns associated with conventional BMP-2 delivery methods. The product is designed to provide localized, sustained release of the growth factor to promote precise bone formation at the target site. Classified as a medical device/biologic combination product, it received FDA Breakthrough Device Designation in January 2024. While its lead indication is interbody spinal fusion, the platform technology has potential applications in cartilage, dental, and skin regeneration.
- Brand names
- RENOVITE BMP-2
- Other names
- RENOVITERENOVITE nanoclayRenovos-BMP-2Renovos-BMP2Renovos-BMP 2
02
Targets
BMP2 (Bone morphogenetic protein 2)
Beyond the preview
Go deeper on RENOVITE BMP-2 (Renovos Biologics).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RENOVITE BMP-2 (Renovos Biologics).